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Abstract 
AIM: 
The aim of the study was to investigate the utility of NT-proBNP measurement for the stratification of 
presurgical cardiac risk. 
METHODS: 
Cardiac risk before elective non-cardiac surgery was evaluated in 82 consecutive patients. From each 
patient a venous blood sample was drawn to determinate NT-proBNP levels. Patients were followed up over 
three months in order to detect the occurrence of cardiac adverse events. 
RESULTS: 
NT-proBNP was positively correlated (P<0.0001) with age, days of hospitalization (P=0.001) and ASA class 
(P=0.001). High surgical risk (P<0.0001), diabetes (P=0.004), dyslipidemia (P=0.006) and elevated levels of 
NT-proBNP (P<0.0001) were significantly correlated with events. Using a logistic regression analysis we 
found an independent association between pre-operative elevated NT-proBNP and postoperative cardiac 
events (OR 1.2, 95% CI 1.0-1.4, P=0.01). 
CONCLUSION: 
Measuring NT-proBNP before non cardiac surgery in clinical practice could be useful to better stratify 
patients' risk. 
 
